PARIS (Reuters) – French Industry Minister Agnes Pannier-Runacher said on Wednesday that Sweden-based pharmaceutical company Recipharm has signed a letter of intent with U.S. firm Moderna to produce some of its COVID-19 vaccine candidate in France.
Pannier-Runacher said that Recipharm has four plants in France.
The head of the European Commission said on Tuesday that the European Union has struck a deal for up to 160 million doses of Moderna’s COVID-19 vaccine candidate, taking the EU’s potential stock of COVID-19 doses to nearly 2 billion.
(Reporting by Matthias Blamont; Writing by Matthieu Protard; Editing by Louise Heavens)
